Here to share my own research & analysis, and to promote @FNArena. Expect to be challenged in your convictions, assuming you're sufficiently open-minded ;)
"Despite a -60% share price decline this year, Morgan Stanley sees further downside risk."
Not exactly what shareholders in Lendlease Group $LLC want to read.
Not to mention all those value investors that have been piling in over the past 2-3 years.
Some cheap looking share prices simply deserve to be cheap (and can always get a whole lot cheap-er).
#stockinfocus #ASX #investing @FNArena
@StockproCapital LOL. I do not disagree with your logic (unless one doesn't trust the numbers) but equally so, I am quoting another expert.
I do not necessarily agree with all the expert quotes I share on this platform.
I am informing, which is not the same as expressing my own views.
"Nvidia has just forecast a staggering $130 billion quarter without counting on a single dollar of Chinese data centre revenue, as its chair closes the door on any return for Jensen Huang.
"Nvidia Chair Harvey Jones says the board doesn’t intend to reinstate Huang as CEO, ending speculation about a comeback for the co-founder less than a week after his abrupt resignation.
"The boss of one of the world’s largest independent financial advisory organisations says the results should hand AI investors fresh confidence after one of the most turbulent weeks in the company’s history.
"Nigel Green, CEO of deVere Group, comments: “Nvidia has just been through one of the worst weeks in its history.
“It lost its founder in dramatic fashion, the board has now made clear he isn’t coming back, and it got hit with new US restrictions on China.
“Its answer is a forecast that beats everyone’s expectations, with China left out entirely.
“This is huge for investors. It shows AI spending is being driven by companies and governments who see the tech as essential, and they’re likely to keep spending big.”
#investing #AI
"#AristocratLeisure's strong North American Gaming performance underpins its growth outlook, while the appointment of a new CEO brings some uncertainty." @FNArena
Aristocrat’s Winning Hand And A New CEO https://t.co/Ct9MUsiFAr
RBC Capital on Nuix $NXL: "US private equity firm Haveli Investments seeing value in Nuix and have approached the company with an unsolicited, non-binding indicative proposal to buy all shares of Nuix for A$2.75 per share by scheme of arrangement, representing a ~73% premium to the last close of A$1.59.
"Crunching the numbers on RBCe FY27 estimates, the deal represents ~2.9x EV/Sales, ~8.9x EV/U EBITDA, and ~24.8x P/U EPS, not an unreasonable multiple given Nuix's low-mid teens ACV growth outlook.
"The main risks are on deal terms and timing - we note that there are several conditions attached, including a 5-week exclusivity period (no shop, no talk, no due diligence), satisfactory completion of due diligence, Haveli receiving final internal approvals, entry into a binding scheme implementation deed, and the usual regulatory/shareholder approvals and unanimous board recommendation.
"Having said that, the board intends to unanimously recommend a binding proposal at a price of $2.75/share or above, with both Nuix's largest shareholder, Macquarie Corporate Holdings (~28%), and directors indicating their intention to vote in favour of the proposal.
"Haveli also intends to fund the deal with committed debt and its own funds, hence, no condition on Haveli receiving financing."
#stockinfocus #ASX #investing
Citi on Infratil $IFT: "Infratil Limited (https://t.co/SlMQJibwjz) Buy
1H27 results: Results strong, FY27 EBITDA guidance upgraded by 2.5% and stands 7% ahead of VA consensus
"IFT today reported its 1H27 results. Proportionate operational EBITDA was NZ$710.6m with total proportionate EBITDAF at NZ$599.3m. For FY27 IFT has raised proportionate operational EBITDA guidance to NZ$1,370-1,440m, +2.5% from investor day (1320-1420) and 4% from May FY26 results (1300-1400). Key contributors to the upgrade were higher contributions from CDC (+NZ10m proportionate impact at mid-point), One NZ (+$5m), FX upside ($10m), and greater confidence in 2H delivery.
"1H27 capex was NZ$2.1 billion and FY27 proportionate capex guidance was increased to NZ$4,150-4,450m, +5% vs prior guidance of NZ$3,800-4,400m. During the half CDC delivered 90MW of operating capacity and Longroad delivered 600MW of capacity, with 810MW and 2GW of capacity under construction respectively for both businesses driving future upside.
"IFT is reacting strongly to the result and is up 3% in NZ. We expect questions on the results call around guidance upgrade, and CDC/Longroad further contracting outlook."
#stockinfocus #ASX #investing
Macquarie on TechOne $TNE: " Expensive, but Executing
"Execution remains strong. ARR & PBT at top end of guidance, NRR improved to 117% CC and AI driving ARR inflection, with A$30m upside.
"Long-term target looks conservative. A$1b+ ARR by FY30 implies ~11% CAGR, well below 16–18% guide, with TNE targeting the top end.
"AI supports valuation. Despite trading at 24x 2Y fwd EV/EBITDA, TNE is the first software stock we cover showing AI monetisation + margin expansion."
#stockinfocus #ASX #investing
RBC Capital on Suncorp Group $SUN: "We initiate coverage on SUN with an Outperform rating and A$23.00 price target.
"SUN is our preferred pick amongst the Australian listed general insurers, offering the most compelling combination of earnings growth, capital returns, and balance sheet optionality in the sector.
"An attractive capital return story. We bake in A$900m of buybacks across FY27-29E, including A$250m announced buybacks in FY27. This is underpinned by a predictable earnings stream driven by its 5YR aggregate reinsurance cover.
"Combined with a strong balance sheet, SUN should sustain buybacks with a level of certainty that its peers cannot replicate. What's more, SUN has balance sheet optionality - it could unlock up to A$1.6bn of CET1 capital via quota share reinsurance or A$800m by increasing gearing to 40% debt and AT1 to tangible capital (currently 29%).
"We forecast ~10% FY26-29E cash NPAT CAGR, though FY27E growth of ~21% is assisted by easier Y/Y comparisons following elevated peril costs. Investment income is a tailwind, and we bake in ~5.8% investment yield in FY27/28E.
"Further including buybacks, our ~12% FY26-29E cash EPS CAGR forecast is double the ~6% at IAG/QBE. Our earnings growth is underpinned by a stable underlying insurance margin across FY27-29E of ~11.5%, towards the upper end of 10-12% FY27 guidance.
"We forecast GWP growth of ~4% FY26-29E CAGR. Importantly, SUN has outpaced IAG on underlying growth. SUN's Home & Motor premiums grew at ~9% FY24-26 CAGR vs ~8% at IAG, while it grew Commercial & Personal Injury at ~8% FY24-26 CAGR versus ~3% at IAG. We do acknowledge that SUN's Home book growth has not been as strong as expected.
"Valuation: SUN trades on ~17.5x 12-month forward P/E or 1.5x PE points below IAG, which looks reasonable given the ~12% FY26-29E EPS CAGR, ~4.5% dividend yield (FY28E), and cash RoNTA improving to ~25% by FY29E.
"Risks include market share losses to challenger brands (SUN has lost ~240bp of Home and Motor share since FY20), softening personal lines pricing (especially Motor) and lower interest rates. AI is a double-edged sword - it could expose the front book to greater competition and accelerate self-driving vehicles - but also deliver operating savings."
#stockinfocus #ASX #Insurance #investing
RBC Capital on Catapult Sports $CAT: "The 1H27 result was solid, with all the key metrics moving in the right direction, steady free cash flow, and a cashed up balance sheet.
"Cross-sell of multiple products has been building strongly, but from here the pace should step up due to the recently launched soccer scouting video module.
"The market reaction is somewhat perplexing, but as a famous general once said, "never interrupt your enemy when he is making a mistake".
"We maintain our Outperform rating and view the selloff as a buying opportunity."
#stockinfocus #ASX #investing
"#PaladinEnergy tapped the market for fresh capital to advance construction at its Patterson Lake South uranium project, while the #U3O8 spot market was disrupted by the global Microsoft outage" @FNArena
Uranium Week: Paladin Taps Market For Cash https://t.co/eQygQI8lVL
RBC Capital on Isurance Australia Group $IAG: "Initiating at Sector Perform: As personal lines pricing tailwinds fade and unit growth becomes increasingly challenging, we see the runway for growth shortening.
"We bake in ~4% GWP CAGR across FY26-29E and ~5% earnings CAGR. Indeed, while inorganic growth opportunities and capital management optionality present upside to our earnings forecasts, we think current valuation multiples are full. Trading on ~19x 12m fwd P/E or 107% P/E Rel (vs. ASX200), IAG is trading at a 10% premium to its 3YR average.
"Elevated competition in Motor weighing on organic growth: Our channel checks indicate competition in Motor remains elevated. Combined with lower Motor claims frequency YTD and ~400bp (730bp ex RACQ) market share losses in Motor since FY20, we think IAG has limited near-term pricing and volume levers to pull. What's more, commercial & personal injury growth has lagged peers over the past 3 years. We view FY27 GWP guidance as optimistic, despite IAG recently reaffirming the 5-8% range in Oct-26.
"RACI is a swing factor for growth vs capital returns: We estimate IAG's proposed acquisition of RACI in WA could give IAG ~7% earnings accretion on a normalised 87.5% COR or ~14% at 70% COR per FY26 levels. Our view is the acquisition is unlikely to proceed (less than 50% probability) as ACCC has objected twice. In this scenario, we estimate IAG has ~A$1.2bn excess PCA capital to enable A$800m of buybacks across FY28-29E.
"Capital mix is optimised: While the buyback pathway remains uncertain, capital buffers are running well above regulatory minimums. But relative to peers, IAG's capital structure carries the most gearing with debt and AT1 to tangible capital of ~45%.
"We view IAG's capital structure as optimised with multi-year quota share reinsurance contracts accounting for ~35% of capital. Alongside its 5YR aggregate cover, IAG's reinsurance provides it with a low volatility earnings stream. The profit commissions on its quota share and aggregate reinsurance covers present upside margin risk.
"Risks include market share losses to challenger brands (IAG has lost ~410bp of Home & Motor share since FY20 ex RACQ acquisition), softening personal pricing, limited pricing in commercial, lower interest rates and a stronger AUD/NZD headwind on New Zealand operations (~20% of GWP)."
#stockinfocus #ASX #Insurance #investing
RBC Capital on $QBE Insurance: "We initiate coverage on QBE with a Sector Perform rating and a A$27.00 price target. QBE's earnings profile is improving, but we see current valuation as broadly fair. Trading on ~12.5x 12-month forward P/E, it is at a discount to SUN and IAG, but roughly in line with the global P&C insurer median.
"While an ROE of ~18% is attractive, the trajectory for further improvement is flattening, which in our view limits meaningful re-rating potential from here. Facing a soft pricing cycle, we forecast GWP growth of ~4.5% FY26-29E CAGR, modestly ahead of domestic insurer peers (IAG/SUN ~4%). But we think risks to GWP growth are skewed to the upside given QBE's unique growth options.
"QBE is emerging as the leading global insurer on broker facilities, with QBE Portfolio Solutions (QPS) writing ~US$1.8bn of premiums in FY26 and set to grow at a double-digit pace in FY27E. QBE has a 50% line on Marsh Fast Track and 28% on Aon Client Treaty, and we think this adds ~US$350m of new premium in FY27 as both facilities raise placements. QBE's appointment as managing agent on Cortina 1956 - a new Lloyd's Aon reinsurance syndicate backed by Blackstone capital and launching in January 2027 - offers a capital-light, ROE-enhancing fee stream. But investors are likely to want visibility on profitability of before giving QBE full credit.
"But QBE faces a meaningful commercial pricing headwind. Renewal rate increases slowed to just +0.3% in 1H26, Lloyd's pricing has turned negative, and US P&C commercial rates continue to trend lower. While QBE has undertaken a multi-year remediation addressing profitability, the commercial pricing cycle has turned, and we expect a broadly flat ~92.5% COR across FY26-29E. Indeed, QBE's strong reserving position should limit risks of COR deterioration in our view. But it is difficult to give full credibility to this strength without more disclosures.
"We forecast mid-single-digit adjusted NPAT growth of ~5% FY26-29E CAGR, with adjusted EPS growth stepping up to ~5.5% CAGR including US$400m buyback in FY27E. QBE likely has more buybacks in store beyond FY28E, but we think the earnings stream is not stable enough to incorporate these for now. Our earnings estimates are ~3% ahead of consensus in FY26/27E. QBE can re-rate higher if it delivers robust top-line premium growth in a soft pricing cycle and continues to improve earnings quality."
#stockinfocus #ASX #Insurance #investing
This week's stock snacks @FNArena
"This week's In Brief highlights #Acrow's accelerating earnings growth, the potential upside for #Myer from David Jones' administration, and #Pharmx Technologies' ambitions to unlock greater value from its pharmacy network."
In Brief: Acrow, Myer & PharmX Technologies https://t.co/D2Fcj3cn8a
"The US midterm elections have injected uncertainty and volatility into the AI infrastructure build-out, but the underlying investment trends remain intact, while the benefits of AI adoption are becoming increasingly evident."
Interesting observations on #ProMedicus in this article and much more @FNArena
The AI March: Deferred, Not Denied https://t.co/a7O14lOwLx
Citi on Aristocrat Leisure $ALL: "Aristocrat reported EBITA (incl JVs) of $2,236 million, ~2% ahead of Citi and and ~1% ahead of VA consensus.
"Revenue was in line with Citi and VA consensus. By divisional profit, Gaming and Product Madness beat while Interactive again materially missed Citi and VA consensus.
"CEO Trevor Croker has announced his intention to retire in April 2027.
"Daphne Guisard (current Chief Commercial Officer of EMEA and Head of Product Madness) has been named CEO (elect).
"A final dividend of 51 cps was announced, ahead of Citi (48 cps)."
#stockinfocus #ASX #investing